O'Brien Laura C, Keeney Paula M, Bennett James P
1 Department of Physiology and Biophysics, Virginia Commonwealth University , Richmond, Virginia.
2 VCU Parkinson's and Movement Disorders Center, Virginia Commonwealth University , Richmond, Virginia.
Stem Cells Dev. 2015 Sep 1;24(17):1984-94. doi: 10.1089/scd.2015.0076. Epub 2015 May 20.
Differentiation of human pluripotent stem cells (hPSCs) in vitro offers a way to study cell types that are not accessible in living patients. Previous research suggests that hPSCs generate ATP through anaerobic glycolysis, in contrast to mitochondrial oxidative phosphorylation (OXPHOS) in somatic cells; however, specialized cell types have not been assessed. To test if mitobiogenesis is increased during motor neuron differentiation, we differentiated human embryonic stem cell (hESC)- and induced pluripotent stem cell-derived human neural stem cells (hNSCs) into motor neurons. After 21 days of motor neuron differentiation, cells increased mRNA and protein levels of genes expressed by postmitotic spinal motor neurons. Electrophysiological analysis revealed voltage-gated currents characteristic of excitable cells and action potential formation. Quantitative PCR revealed an increase in peroxisome proliferator-activated receptor gamma coactivator 1-α (PGC-1α), an upstream regulator of transcription factors involved in mitobiogenesis, and several of its downstream targets in hESC-derived cultures. This correlated with an increase in protein expression of respiratory subunits, but no increase in protein reflecting mitochondrial mass in either cell type. Respiration analysis revealed a decrease in glycolytic flux in both cell types on day 21 (D21), suggesting a switch from glycolysis to OXPHOS. Collectively, our findings suggest that mitochondrial biogenesis, but not mitochondrial mass, is increased during differentiation of hNSCs into motor neurons. These findings help us to understand human motor neuron mitobiogenesis, a process impaired in amyotrophic lateral sclerosis, a neurodegenerative disease characterized by death of motor neurons in the brain and spinal cord.
体外分化人多能干细胞(hPSC)为研究活体患者无法获取的细胞类型提供了一条途径。先前的研究表明,与体细胞中的线粒体氧化磷酸化(OXPHOS)不同,hPSC通过无氧糖酵解产生ATP;然而,尚未对特殊细胞类型进行评估。为了测试在运动神经元分化过程中线粒体生物合成是否增加,我们将人胚胎干细胞(hESC)和诱导多能干细胞衍生的人神经干细胞(hNSC)分化为运动神经元。在运动神经元分化21天后,细胞中由有丝分裂后脊髓运动神经元表达的基因的mRNA和蛋白质水平增加。电生理分析揭示了可兴奋细胞特有的电压门控电流和动作电位形成。定量PCR显示,在hESC衍生的培养物中,参与线粒体生物合成的转录因子的上游调节因子过氧化物酶体增殖物激活受体γ共激活因子1-α(PGC-1α)及其几个下游靶点增加。这与呼吸亚基蛋白表达的增加相关,但两种细胞类型中反映线粒体质量的蛋白质均未增加。呼吸分析显示,两种细胞类型在第21天(D21)的糖酵解通量均下降,表明从糖酵解转变为OXPHOS。总体而言,我们的研究结果表明,在hNSC分化为运动神经元的过程中,线粒体生物合成增加,但线粒体质量未增加。这些发现有助于我们理解人类运动神经元的线粒体生物合成,这一过程在肌萎缩侧索硬化症中受损,肌萎缩侧索硬化症是一种以脑和脊髓运动神经元死亡为特征的神经退行性疾病。